Objective:

To evaluate the association between achieved systolic blood pressure (SBP) levels and major adverse cardiovascular events (MACE), all-cause mortality, and adverse treatment events in high-risk hypertensive patients.

Approach:

Key Findings:

• Lower achieved SBP (<120 mmHg) was associated with significantly fewer MACE events compared to higher SBP (14.8 vs. 26.5, p = 0.03) over a median follow-up of 18 months.
• Relative risk reduction of 30% was noted in patients with diabetes and chronic kidney disease.
• Adverse events were slightly more common in the lower SBP group but remained clinically manageable (9.3% vs. 4.8%; p = 0.60).

Interpretation:

Lower achieved SBP levels in high-risk hypertensive patients correlate with reduced cardiovascular event rates, particularly in those with diabetes and chronic kidney disease, though results should be interpreted cautiously due to study limitations.

Limitations:

• Study is retrospective, which may limit the applicability of findings.
• Potential confounding factors, such as medication adherence and lifestyle changes, were not controlled for in the analysis.

Conclusion:

Further prospective studies are needed to define optimal BP targets, especially in high-risk populations.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.